PD-L1

Han Wang1, Xiao-Hong Ding1,2, Cheng-Lin Liu1

  • 1Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

概括

基因组变化可以悖论地影响瘤透淋巴细胞 (TIL) 和PD-L1表达在三阴性乳腺癌,影响患者的预后和免疫治疗反应. 了解这些因素是精密治疗的关键.